Web Analytics

3 Latest Announced Rounds

  • $10,000,000
    Unknown

    3 Investors

    Computer & Network Security
    Apr 24th, 2025
  • $3,000,000
    Seed

    2 Investors

    Medical Equipment Manufacturing
    Apr 24th, 2025
  • $3,000,000
    Seed

    4 Investors

    Software Development
    Apr 24th, 2025
$2,018.11M Raised in 62 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Brightstar Therapeutics

start up
United States - Lexington, Kentucky
  • 21/04/2023
  • Series A
  • Undisclosed Amount

Brightstar Therapeutics is a biotechnology company focused on providing innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases.

Brightstar Therapeutics is the first company to offer a long-term solution for persistent epithelial defects, and partial limbal stem cell deficiency through its advanced corneal allograft, BrightMEM.


Related People

Rajan ShuklaFounder

Rajan Shukla United States - Lexington, Kentucky

N/A